Abstract
Patients with de novo acute myeloid leukemia (AML) and near-tetraploid or completely tetraploid karyotype at presentation are rare. We present four patients with near-tetraploidy/tetraploidy in a cohort of 426 consecutive AML patients (0.98%) in respect to their cytogenetic findings, immunophenotype pattern, response to chemotherapy, course of disease and molecular analyses including tyrosine kinase receptor FLT3 gene, NRAS gene, and tumour suppressor gene, p53. We have found FLT3/ITD mutation only in one patient among the four with near-tetraploidy. The main finding is that these patients had a variable clinical course, with two having a long period of remission (36 and 12 months) and two died, not having achieved remission.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abe R., Raza A., Preister H. D., Tebbi C. K. and Sandberg A. A. 1985 Chromosomes and causaltori of human cancer and leukemia. Near-tetraploidy in acute leukemia. Cancer Genet. Cytogenet. 14, 45–59.
Bennett J.M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R. and Sultan C. 1985 Proposed revised criteria for the classification of acute myeloid leukemia. Am. J. Intern. Med. 103, 626–629.
Čolović M., Jurišić V., Pavlović S., Terzić T. and Čolović N. 2006 FLT3/D835 mutation and inversion of chromosome 16 in leukemic transformation of myelofibrosis. Eur. J. Int. Med. 17, 434–43
Čolović N., Tošić N., Aveić S., Djurić M., Milić N., Bumbaširević V. et al. 2007 Importance of early detection and follow up of FLT3 mutation in patients with acute myeloid leukemia. Ann. Hematol. 86, 741–74
Kottaridis P. D., Gale R. E., Frew M. E., Harrison G., Langabeer S. E., Belton A. A. et al. 2001 The presence of a FLT3 tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98, 1752–1759.
Kwong Y. L. and Wong K. F. 1995 Hyperdiploid acute myeloid leukemia. Relationship between blast size and karyotype demonstarted by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 83, 1–4.
Shaffer L. G. and Tommerup N. (ed.) 2005 An international system for human cytogenetic nomenclature. Karger, Basel.
Stirewalt D. L., Kopecky K. J., Meshinchi S., Appelbaum F. R., Slovak M. L., Willman C. L. and Radich J. P. 2001 FLT3, RAS and p53 mutations in elderly patients with acute myeloid leukemia. Blood 97, 3589–3595.
Testa J. R., Oguma N., Pollak A. and Wiernik P. 1983 Neartetraploid clones in acute leukemia. Blood 61, 71–78.
Watanabe A., Inokuchi K., Yamaguchi K., Mizuki T., Tanosaki S., Shimada T. and Dan K. 2004 Near tetraploidy and neartetraploidy in hematological malignancies and mutation of the p53 gene. Clin. Lab. Haem. 26, 25–30.
Yamamoto Y., Kiyoi H., Nakano Y., Suzuki R., Kodera Y., Miyawaki S. et al. 2001 Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97, 2434–2439.
Yeh S. P., Wang Y., Su J., Hsueh E., Yu M. and Wu H. 2000 Neartetraploid minimally differentiated acute myeloid leukemia with extensive erythrophagocytosis by leukemic blasts. Ann. Hematol. 79, 36–39.
Yamamoto K., Nagata K., Kida A., Tsurukubo Y. and Hamaguchi H. 2001 CD7+ near- tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocation and AML1/ETO rearrangements detected by fluorescence in situ hybridization. Int J. Hematol. 74, 316–321.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jurišić, V., Pavlović, S., Čolović, N. et al. Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia. J Genet 88, 149–152 (2009). https://doi.org/10.1007/s12041-009-0022-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-009-0022-1